◆英語タイトル：OncBioMune Pharmaceuticals Inc (OBMP) - Financial and Strategic SWOT Analysis Review
OncBioMune Pharmaceuticals Inc (OncBioMune), formerly Quint Media Inc is a biopharmaceutical company that develops novel cancer immunotherapy products. The company’s products comprise biosimilars and vaccines developed for cancer types such as renal, breast, prostrate, and ovarian cancer. Its lead products OvcaVax for treating ovarian cancer and ProscaVax, a therapeutic vaccine is developed for prostate cancer patients. OncBioMune also utilizes Targeted Transferrin Transport Technology to deliver cytotoxic agents targeted selectively to the cancer cell and reduce effect on normal cells. The company’s products attacks iron metabolism of cancer cells and prevent iron storage into the protein ferritin with its technology. It also has a portfolio of targeted therapies such as paclitaxel. OncBioMune is headquartered in Baton Rouge, Louisiana, the US.
OncBioMune Pharmaceuticals Inc Key Recent Developments
Jan 28,2019: OncBioMune Pharmaceuticals names Dr. Mitesh Borad as Scientific Advisory Board
Jan 09,2019: OncBioMune announces former Puma Biotechnology Executive and Genentech Veteran Brian Barnett, M.D., as Chief Executive Officer
Nov 08,2018: OncBioMune Phase 2 Clinical Trial to Begin Enrollment; Company Announces Other Developments and Corporate Milestones
Oct 31,2018: OncBioMune CEO Dr. Jonathan Head Speaking at 2018 Global Summit on Genitourinary Malignancies
Oct 11,2018: OncBioMune Advancing ProscaVax Towards Second Phase 2 Clinical Trial for Prostate Cancer with Protocol Submission to FDA
This comprehensive SWOT profile of OncBioMune Pharmaceuticals Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of OncBioMune Pharmaceuticals Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 – About the Company
OncBioMune Pharmaceuticals Inc – Key Information
OncBioMune Pharmaceuticals Inc – Overview
OncBioMune Pharmaceuticals Inc – Key Employees
OncBioMune Pharmaceuticals Inc – Key Employee Biographies
OncBioMune Pharmaceuticals Inc – Key Operational Heads
OncBioMune Pharmaceuticals Inc – Major Products and Services
OncBioMune Pharmaceuticals Inc – History
OncBioMune Pharmaceuticals Inc – Company Statement
OncBioMune Pharmaceuticals Inc – Locations And Subsidiaries
OncBioMune Pharmaceuticals Inc – Key Manufacturing facilities
Other Locations & Subsidiaries
Section 2 – Company Analysis
OncBioMune Pharmaceuticals Inc – Business Description
OncBioMune Pharmaceuticals Inc – Corporate Strategy
OncBioMune Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
OncBioMune Pharmaceuticals Inc – Strengths
OncBioMune Pharmaceuticals Inc – Weaknesses
OncBioMune Pharmaceuticals Inc – Opportunities
OncBioMune Pharmaceuticals Inc – Threats
OncBioMune Pharmaceuticals Inc – Key Competitors
Section 3 – Company Financial Performance Charts
OncBioMune Pharmaceuticals Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Appendix
Note*: Some sections may be missing if data is unavailable for the company
List of Tables
OncBioMune Pharmaceuticals Inc, Key Information
OncBioMune Pharmaceuticals Inc, Key Ratios
OncBioMune Pharmaceuticals Inc, Share Data
OncBioMune Pharmaceuticals Inc, Major Products and Services
OncBioMune Pharmaceuticals Inc, History
OncBioMune Pharmaceuticals Inc, Key Employees
OncBioMune Pharmaceuticals Inc, Key Employee Biographies
OncBioMune Pharmaceuticals Inc, Key Operational Heads
OncBioMune Pharmaceuticals Inc, Other Locations
OncBioMune Pharmaceuticals Inc, Subsidiaries
OncBioMune Pharmaceuticals Inc, Key Manufacturing facilities
OncBioMune Pharmaceuticals Inc, Key Competitors
OncBioMune Pharmaceuticals Inc, SWOT Analysis
OncBioMune Pharmaceuticals Inc, Ratios based on current share price
OncBioMune Pharmaceuticals Inc, Annual Ratios
OncBioMune Pharmaceuticals Inc, Interim Ratios
Capital Market Ratios
List of Figures
OncBioMune Pharmaceuticals Inc, Performance Chart
OncBioMune Pharmaceuticals Inc, Ratio Charts
| ★海外企業調査レポート[OncBioMune Pharmaceuticals Inc (OBMP)：企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら